CHINTAN SHAH: Open Payments
NPI 1871782268 · FORT PIERCE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 39 payments from 18 companies in 2025. Trend: 2023 $759 · 2024 $2,205 · 2025 $2,131
Speaker / faculty: $1,240Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $1,326 |
| GE HEALTHCARE | 1 | $127 |
| Corcept Therapeutics | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Amgen Inc. | 3 | $52 |
| Eisai Inc. | 2 | $51 |
| Novo Nordisk Inc | 2 | $42 |
| Dexcom, Inc. | 2 | $36 |
Products named: Korlym, AUSTEDO XR, Leqembi, ELIQUIS, Ozempic, Dexcom G6 Transmitter, OTEZLA, QULIPTA.
Industry payments across FL — which companies pay providers there.
